Medicine & Life Sciences

1. Immunotherapy 100%
2. Systemic Lupus Erythematosus 77%
3. Rheumatic Diseases 75%
4. Neoplasms 74%
5. Arthritis 66%
6. T-Lymphocytes 59%
7. sirukumab 46%
8. Rheumatoid Arthritis 44%
9. Cell- and Tissue-Based Therapy 43%
10. Genetic Therapy 42%
11. Interferon Type I 33%
12. Myelin-Oligodendrocyte Glycoprotein 32%
13. Preexisting Condition Coverage 32%
14. pembrolizumab 31%
15. Myelitis 31%
16. Myositis 30%
17. Vesicular Stomatitis 29%
18. CD40 Ligand 28%
19. Lupus Nephritis 27%
20. Antinuclear Antibodies 26%
21. Loss of Heterozygosity 26%
22. Melanoma 25%
23. Censuses 24%
24. Immune System Diseases 24%
25. Therapeutics 23%
26. Interferons 23%
27. Workload 22%
28. Congresses 22%
29. Patient Safety 22%
30. Transverse Myelitis 21%
31. Immune System 21%
32. Natural Killer Cells 21%
33. Glioma 20%
34. Suicide 20%
35. Adoptive Transfer 20%
36. Compliance 20%
37. Biomarkers 19%
38. Phenotype 18%
39. Vaccination 18%
40. Chromosomes 17%
41. Neutrophils 17%
42. Breast 17%
43. Immunoglobulin G 17%
44. Vaccines 15%
45. Self Tolerance 15%
46. Viruses 15%